ST2 in patients with severe aortic stenosis and heart failure

BACKGROUND: ST2 is a circulating biomarker that is well established for predicting outcome in heart failure (HF). This is the first study to look at ST2 concentrations in optimally treated patients with stable but significant left ventricular systolic dysfunction (LVSD) compared to patients with sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Andrew, Miyazawa, Alejandra, Sunderland, Nicholas, Piper, Susan E., Gibbs, Thomas G.J., Wang, Duolao, Redding, Sadie, Amin-Youseff, George, Wendler, Olaf, Byrne, Jonathan, MacCarthy, Philip A., Shah, Ajay M., McDonagh, Theresa A., Dworakowski, Rafal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105079/
https://www.ncbi.nlm.nih.gov/pubmed/31225635
http://dx.doi.org/10.5603/CJ.a2019.0052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105079/
https://www.ncbi.nlm.nih.gov/pubmed/31225635
http://dx.doi.org/10.5603/CJ.a2019.0052

Ejemplares similares